-
2
-
-
85013312416
-
Tumor angiogenesis: Therapeutic implications
-
Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
3
-
-
0028929803
-
Angiogenesis in cancer, vascular, rheumatoid and other disease
-
Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
-
(1995)
Nat Med
, vol.1
, pp. 27-31
-
-
Folkman, J.1
-
4
-
-
0026081739
-
Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
-
Le Noble FA, Hekking JW, van Straaten HW, Slaaf DW and Struyker Boudier HA: Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195: 305-306, 1991.
-
(1991)
Eur J Pharmacol
, vol.195
, pp. 305-306
-
-
Le Noble, F.A.1
Hekking, J.W.2
Van Straaten, H.W.3
Slaaf, D.W.4
Struyker Boudier, H.A.5
-
5
-
-
0027537010
-
Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioal-lantoic membrane
-
Le Noble FA, Schreurs NH, van Straaten HW, et al: Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioal-lantoic membrane. Am J Physiol 264: 460-465, 1993.
-
(1993)
Am J Physiol
, vol.264
, pp. 460-465
-
-
Le Noble, F.A.1
Schreurs, N.H.2
Van Straaten, H.W.3
-
6
-
-
1542547460
-
Identification of Telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
-
Benson SC, Pershadsingh HA, Ho CI et al: Identification of Telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ- modulating activity. Hypertension 43: 993-1002, 2004.
-
(2004)
Hypertension
, vol.43
, pp. 993-1002
-
-
Benson, S.C.1
Pershadsingh, H.A.2
Ho, C.I.3
-
7
-
-
0032475922
-
Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
-
DOI 10.1074/jbc.273.40.25573
-
Chinetti G, Griglio S, Antonucci M, et al: Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580, 1998. (Pubitemid 28475776)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.40
, pp. 25573-25580
-
-
Chinetti, G.1
Griglio, S.2
Antonucci, M.3
Torra, I.P.4
Delerive, P.5
Majd, Z.6
Fruchart, J.-C.7
Chapman, J.8
Najib, J.9
Staels, B.10
-
8
-
-
0031898610
-
PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
-
Spiegelman BM: PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514, 1998.
-
(1998)
Diabetes
, vol.47
, pp. 507-514
-
-
Spiegelman, B.M.1
-
9
-
-
0031993322
-
Terminal Differentiation of Human Breast Cancer through PPARgamma
-
Mueller E, Sarraf P, Tontonoz P, et al: Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1: 465-470, 1998. (Pubitemid 128378895)
-
(1998)
Molecular Cell
, vol.1
, Issue.3
, pp. 465-470
-
-
Mueller, E.1
Sarraf, P.2
Tontonoz, P.3
Evans, R.M.4
Martin, K.J.5
Zhang, M.6
Fletcher, C.7
Singer, S.8
Spiegelman, B.M.9
-
10
-
-
0031671246
-
Differentiation and reversal of malignant changes in colon cancer through PPARgamma
-
DOI 10.1038/2030
-
Sarraf P, Mueller E, Jones D, et al: Differentiation and reversal of malignant changes in colon cancer through PPAR-gamma. Nat Med 4: 1046-1052, 1998. (Pubitemid 28417337)
-
(1998)
Nature Medicine
, vol.4
, Issue.9
, pp. 1046-1052
-
-
Sarraf, P.1
Mueller, E.2
Jones, D.3
King, F.J.4
Deangelo, D.J.5
Partridge, J.B.6
Holden, S.A.7
Chen, L.B.8
Singer, S.9
Fletcher, C.10
Spiegelman, B.M.11
-
11
-
-
0034643258
-
Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis
-
DOI 10.1006/bbrc.2000.2436
-
Tsubouchi Y, Sano H, Kawahito Y, et al: Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis. Biochem Biophys Res Commun 270: 400-405, 2000. (Pubitemid 30446848)
-
(2000)
Biochemical and Biophysical Research Communications
, vol.270
, Issue.2
, pp. 400-405
-
-
Tsubouchi, Y.1
Sano, H.2
Kawahito, Y.3
Mukai, S.4
Yamada, R.5
Kohno, M.6
Inoue, K.-I.7
Hla, T.8
Kondo, M.9
-
12
-
-
0032586875
-
Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells
-
DOI 10.1016/S0014-5793(99)00871-6, PII S0014579399008716
-
Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I and Kohgo Y: Activation of PPAR gamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett 455: 135-139, 1999. (Pubitemid 29322796)
-
(1999)
FEBS Letters
, vol.455
, Issue.1-2
, pp. 135-139
-
-
Takahashi, N.1
Okumura, T.2
Motomura, W.3
Fujimoto, Y.4
Kawabata, I.5
Kohgo, Y.6
-
13
-
-
0030612740
-
PPARgamma induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
-
Altiok S, Xu M and Spiegelman BM: PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11: 1987-1998, 1997.
-
(1997)
Genes Dev
, vol.11
, pp. 1987-1998
-
-
Altiok, S.1
Xu, M.2
Spiegelman, B.M.3
-
14
-
-
0033546190
-
2
-
Bishop-Bailey D and Hla T: Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12,14- prostaglandin J2. J Biol Chem 274: 17042-17048, 1999. (Pubitemid 129519033)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.24
, pp. 17042-17048
-
-
Bishop-Bailey, D.1
Hla, T.2
-
15
-
-
0035964872
-
Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists
-
DOI 10.1006/bbrc.2001.5640
-
Inoue K, Kawahito Y, Tsubouchi Y, et al: Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. Biochem Biophys Res Commun 287: 727-732, 2001. (Pubitemid 32912775)
-
(2001)
Biochemical and Biophysical Research Communications
, vol.287
, Issue.3
, pp. 727-732
-
-
Inoue, K.-I.1
Kawahito, Y.2
Tsubouchi, Y.3
Kohno, M.4
Yoshimura, R.5
Yoshikawa, T.6
Sano, H.7
-
16
-
-
0037401046
-
Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists
-
DOI 10.1002/ijc.10980
-
Yoshimura R, Matsuyama M, Segawa Y, et al: Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer 104: 597-602, 2003. (Pubitemid 36337259)
-
(2003)
International Journal of Cancer
, vol.104
, Issue.5
, pp. 597-602
-
-
Yoshimura, R.1
Matsuyama, M.2
Segawa, Y.3
Hase, T.4
Mitsuhashi, M.5
Tsuchida, K.6
Wada, S.7
Kawahito, Y.8
Sano, H.9
Nakatani, T.10
-
17
-
-
0036570532
-
Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer
-
DOI 10.1002/pros.10058
-
Segawa Y, Yoshimura R, Hase T, et al: Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate 51: 108-116, 2002. (Pubitemid 34492617)
-
(2002)
Prostate
, vol.51
, Issue.2
, pp. 108-116
-
-
McEleny, K.R.1
William G Watson, R.2
Coffey, R.N.T.3
O'Neill, A.J.4
Fitzpatrick, J.M.5
-
18
-
-
0036754728
-
Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists
-
DOI 10.1016/S0090-4295(02)01747-8, PII S0090429502017478
-
Hase T, Yoshimura R, Mitsuhashi M, et al: Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology 60: 542-547, 2002. (Pubitemid 35292201)
-
(2002)
Urology
, vol.60
, Issue.3
, pp. 542-547
-
-
Hase, T.1
Yoshimura, R.2
Mitsuhashi, M.3
Segawa, Y.4
Kawahito, Y.5
Wada, S.6
Nakatani, T.7
Sano, H.8
-
19
-
-
5744228122
-
The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells
-
Yoshimura R, Matsuyama M, Hase T, et al: The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. Int J Mol Med 12: 861-865, 2003.
-
(2003)
Int J Mol Med
, vol.12
, pp. 861-865
-
-
Yoshimura, R.1
Matsuyama, M.2
Hase, T.3
-
20
-
-
48749090567
-
Telmisartan is a potent target for prevention and treatment in human prostate cancer
-
In press
-
Funao K, Matsuyama M, Kawahito Y, et al: Telmisartan is a potent target for prevention and treatment in human prostate cancer. Oncol Rep (In press).
-
Oncol Rep
-
-
Funao, K.1
Matsuyama, M.2
Kawahito, Y.3
-
21
-
-
0035852724
-
Angiotensin II type 1 receptor blockers
-
Burnier M: Angiotensin II type 1 receptor blockers. Circulation 103: 904-912, 2001.
-
(2001)
Circulation
, vol.103
, pp. 904-912
-
-
Burnier, M.1
-
22
-
-
0034235328
-
Angiotensin II-receptor antagonists
-
Dina R and Jafari M: Angiotensin II-receptor antagonists. Am J Health Syst Pharm 57: 1231-1241, 2000.
-
(2000)
Am J Health Syst Pharm
, vol.57
, pp. 1231-1241
-
-
Dina, R.1
Jafari, M.2
-
23
-
-
0036732649
-
Old antihypertensives as novel antineoplastics: Angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists
-
DOI 10.1016/S0306-9877(02)00185-8
-
Abali H, Güllü H, Engin H, Haznedaroglu C, Erman M and Tekuzman G: Old antihypertensive as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med Hypotheses 59: 344-348, 2002. (Pubitemid 35042032)
-
(2002)
Medical Hypotheses
, vol.59
, Issue.3
, pp. 344-348
-
-
Abali, H.1
Gullu, I.H.2
Engin, H.3
Haznedarolu, I.C.4
Erman, M.5
Tekuzman, G.6
-
24
-
-
0035957683
-
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist
-
DOI 10.1016/S0014-5793(01)02377-8, PII S0014579301023778
-
Fujimoto Y, Sasaki T, Tsuchida A and Chayama K: Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 495: 197-200, 2001. (Pubitemid 32397704)
-
(2001)
FEBS Letters
, vol.495
, Issue.3
, pp. 197-200
-
-
Fujimoto, Y.1
Sasaki, T.2
Tsuchida, A.3
Chayama, K.4
-
25
-
-
0036681694
-
Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis
-
Miyajima A, Kosaka T, Asano T, et al: Angiotensin II type 1 antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Cancer Res 62: 4176-4179, 2002. (Pubitemid 34830392)
-
(2002)
Cancer Research
, vol.62
, Issue.15
, pp. 4176-4179
-
-
Miyajima, A.1
Kosaka, T.2
Asano, T.3
Asano, T.4
Seta, K.5
Kawai, T.6
Hayakawa, M.7
-
26
-
-
0028175405
-
Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma
-
Goldfarb DA, Diz DI, Tubbs RR, Ferrario CM and Novick AC: Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urol 151: 208-213, 1994. (Pubitemid 2004497)
-
(1994)
Journal of Urology
, vol.151
, Issue.1
, pp. 208-213
-
-
Goldfarb, D.A.1
Diz, D.I.2
Tubbs, R.R.3
Ferrario, C.M.4
Novick, A.C.5
-
27
-
-
0030963531
-
Angiotensin II type 1 receptor expression in human breast tissues
-
Inwang ER, Puddefoot JR, Brown CL, et al: Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer 75: 1279-1283, 1997. (Pubitemid 27179816)
-
(1997)
British Journal of Cancer
, vol.75
, Issue.9
, pp. 1279-1283
-
-
Inwang, E.R.1
Puddefoot, J.R.2
Brown, C.L.3
Goode, A.W.4
Marsigliante, S.5
Ho, M.M.6
Payne, J.G.7
Vinson, G.P.8
-
28
-
-
33646739082
-
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer
-
DOI 10.1158/1078-0432.CCR-05-2213
-
Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y and Murai M: Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer. Clin Cancer Res 12: 2888-2893, 2006. (Pubitemid 43752131)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.9
, pp. 2888-2893
-
-
Kosugi, M.1
Miyajima, A.2
Kikuchi, E.3
Horiguchi, Y.4
Murai, M.5
-
29
-
-
33845777021
-
Angiotensin II type I receptor antagonist as an angiogenic inhibitor in prostate cancer
-
DOI 10.1002/pros.20486
-
Kosaka T, Miyajima A, Takayama E, et al: Angiotensin II type I receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate 67: 41-49, 2007. (Pubitemid 46013466)
-
(2007)
Prostate
, vol.67
, Issue.1
, pp. 41-49
-
-
Kosaka, T.1
Miyajima, A.2
Takayama, E.3
Kikuchi, E.4
Nakashima, J.5
Ohigashi, T.6
Asano, T.7
Sakamoto, M.8
Okita, H.9
Murai, M.10
Hayakawa, M.11
-
30
-
-
85047693609
-
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth
-
DOI 10.1172/JCI200316645
-
Egami K, Murohara T, Shimada T, et al: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112: 67-75, 2003. (Pubitemid 38056377)
-
(2003)
Journal of Clinical Investigation
, vol.112
, Issue.1
, pp. 67-75
-
-
Egami, K.1
Murohara, T.2
Shimada, T.3
Sasaki, K.-I.4
Shintani, S.5
Sugaya, T.6
Ishii, M.7
Akagi, T.8
Ikeda, H.9
Matsuishi, T.10
Imaizumi, T.11
-
31
-
-
13844280904
-
Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore
-
Koh WP, Yuan JM, van den Berg D, Lee HP and Yu MC: Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 26: 459-464, 2005.
-
(2005)
Carcinogenesis
, vol.26
, pp. 459-464
-
-
Koh, W.P.1
Yuan, J.M.2
Van Den Berg, D.3
Lee, H.P.4
Yu, M.C.5
-
32
-
-
29244485406
-
Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer
-
DOI 10.1007/s10147-005-0520-y
-
Uemura H, Hasumi H, Kawahara T, et al: Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer. Int J Clin Oncol 10: 405-410, 2005. (Pubitemid 41821524)
-
(2005)
International Journal of Clinical Oncology
, vol.10
, Issue.6
, pp. 405-410
-
-
Uemura, H.1
Hasumi, H.2
Kawahara, T.3
Sugiura, S.4
Miyoshi, Y.5
Nakaigawa, N.6
Teranishi, J.-I.7
Noguchi, K.8
Ishiguro, H.9
Kubota, Y.10
-
33
-
-
0033925031
-
15-Deoxy-delta (12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
-
Kawahito Y, Kondo M, Tsubouchi Y, et al: 15-Deoxy-delta (12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 106: 189-197, 2000.
-
(2000)
J Clin Invest
, vol.106
, pp. 189-197
-
-
Kawahito, Y.1
Kondo, M.2
Tsubouchi, Y.3
-
34
-
-
0026517010
-
Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
-
Dreyer C, Krey G, Keller H, Givel F, Helftenbein G and Wahli W: Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887, 1992.
-
(1992)
Cell
, vol.68
, pp. 879-887
-
-
Dreyer, C.1
Krey, G.2
Keller, H.3
Givel, F.4
Helftenbein, G.5
Wahli, W.6
-
35
-
-
0026705751
-
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
-
Kliewer SA, Umesono K, Noonan DJ, Heyman RA and Evans EM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774, 1992.
-
(1992)
Nature
, vol.358
, pp. 771-774
-
-
Kliewer, S.A.1
Umesono, K.2
Noonan, D.J.3
Heyman, R.A.4
Evans, E.M.5
-
36
-
-
0028321529
-
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
-
DOI 10.1073/pnas.91.15.7355
-
Kliewer SA, Forman BM, Blumberg B, et al: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994. (Pubitemid 24226862)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.15
, pp. 7355-7359
-
-
Kliewer, S.A.1
Forman, B.M.2
Blumberg, B.3
Ong, E.S.4
Borgmeyer, U.5
Mangelsdorf, D.J.6
Umesono, K.7
Evans, R.M.8
-
37
-
-
0033533535
-
15-Deoxy-Delta (12, 14)-prostaglandin J (2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells
-
Keelan JA, Sato TA, Marvin KW, Lander J, Gilmour RS and Mitchell MD: 15-Deoxy-Delta (12, 14)-prostaglandin J (2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun 262: 579-585, 1999.
-
(1999)
Biochem Biophys Res Commun
, vol.262
, pp. 579-585
-
-
Keelan, J.A.1
Sato, T.A.2
Marvin, K.W.3
Lander, J.4
Gilmour, R.S.5
Mitchell, M.D.6
|